0001209191-22-045184.txt : 20220810
0001209191-22-045184.hdr.sgml : 20220810
20220810160931
ACCESSION NUMBER: 0001209191-22-045184
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220809
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abdun-Nabi Daniel
CENTRAL INDEX KEY: 0001380187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 221151902
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DRIVE
STREET 2: SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-09
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001380187
Abdun-Nabi Daniel
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
1
0
0
0
Restricted Stock Unit
2022-08-09
4
A
0
3571
0.00
A
Common Stock
3571
3571
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
The RSUs vest in full on the first anniversary of the date of grant.
/s/ SoYoung Kwon, Attorney-in-Fact
2022-08-10